OPDIVO

nivolumab · E.R. Squibb & Sons, L.L.C.

Drug timelines are a Plus or Pro feature.

285 regulatory and trial events tracked for OPDIVO, covering 2014-12-22 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Opdivo (nivolumab) — Bristol-Myers Squibb Pharma EEIG